Protagonist Therapeutics Inc
(PTGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,725 | -127,393 | -93,199 | -61,967 | -20,930 |
| Depreciation Amortization | -423 | 2,820 | 2,894 | 2,130 | 1,191 |
| Accounts receivable | -41 | 1,556 | 1,441 | 1,523 | -23,584 |
| Accounts payable and accrued liabilities | 334 | 1,215 | 2,254 | -1,003 | 5,040 |
| Other Working Capital | -7,977 | -7,766 | -4,887 | -4,204 | -23,862 |
| Other Operating Activity | 7,485 | 21,431 | 14,995 | 12,220 | 24,479 |
| Operating Cash Flow | $-34,347 | $-108,137 | $-76,502 | $-51,301 | $-37,666 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -795 | -725 | -563 | -273 |
| Purchase Of Investment | -28,060 | -214,874 | -134,279 | -102,121 | -55,832 |
| Sale Of Investment | 37,896 | 307,137 | 222,537 | 132,942 | 51,629 |
| Investing Cash Flow | $9,826 | $91,468 | $87,533 | $30,258 | $-4,476 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,302 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,261 | 19,001 | 18,448 | 17,766 | 17,111 |
| Other Financing Activity | -100 | -163 | -163 | -161 | -186 |
| Financing Cash Flow | $26,463 | $18,838 | $18,285 | $17,605 | $16,925 |
| Exchange Rate Effect | N/A | -90 | -165 | 10 | 29 |
| Beginning Cash Position | 125,969 | 123,890 | 123,890 | 123,890 | 123,890 |
| End Cash Position | 127,911 | 125,969 | 153,041 | 120,462 | 98,702 |
| Net Cash Flow | $1,942 | $2,079 | $29,151 | $-3,428 | $-25,188 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,347 | -108,137 | -76,502 | -51,301 | -37,666 |
| Capital Expenditure | -10 | -795 | -725 | -563 | -273 |
| Free Cash Flow | -34,357 | -108,932 | -77,227 | -51,864 | -37,939 |